G. Dabouis

发表

Prognostic factors for patients with small cell lung carcinoma

V. Ninane, M. Paesmans, J. Sculier, 2000, Cancer.

Value of Repetitive Transcranial Magnetic Stimulation of the Motor Cortex in the Management of Refractory Cancer Pain in Palliative Care: A Case Report

J. Lefaucheur, S. Raoul, J. Nizard, 2013 .

Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Français de Pneumo-Cancérologie (GFPC) Protocol 95-1.

L. Thiberville, P. Souquet, P. Fournel, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non‐Small‐Cell Lung Cancer

E. Lemarié, J. Dalphin, A. Depierre, 1991, American journal of clinical oncology.

Intrapleural treatment with recombinant gamma‐interferon in early stage malignant pleural mesothelioma

J. Douillard, J. Bignon, J. Guerin, 1994, Cancer.

Phase II study of vinflunine in malignant pleural mesothelioma.

D. Talbot, L. Ollivier, G. Dabouis, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Assayand PolyclonalRadioimmunoassay Compared for MeasuringNeuron-Specific Enolasein PatientswithLungCancer

M. Paesmans, J. Sculier, J. Body, 1992 .

Monoclonal immunoradiometric assay and polyclonal radioimmunoassay compared for measuring neuron-specific enolase in patients with lung cancer.

M. Paesmans, J. Sculier, J. Body, 1992, Clinical chemistry.

Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer. European Lung Cancer Working Party.

M. Paesmans, J. Sculier, J. Thiriaux, 1994, European journal of cancer.

Original article: A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer

M. Paesmans, J. Sculier, J. Klastersky, 1990 .

Aberrant splicing and protease involvement in mesothelin release from epithelioid mesothelioma cells

A. Scherpereel, C. Sagan, M. Grégoire, 2008, Cancer science.

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.

M Paesmans, J P Sculier, M. Paesmans, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the European Lung Cancer Working Party.

M Paesmans, J P Sculier, M. Paesmans, 1997, European journal of cancer.

Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party.

J. Sculier, F. Ries, J. Klastersky, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer.

M. Paesmans, J. Sculier, F. Ries, 1994, Lung cancer.

Pretreatment minimal staging for non-small cell lung cancers: a consensus report

U. Pastorino, R. Stahel, A. Turrisi, 1991 .

Evidence for two distinct alpha(1,2)-fucosyltransferase genes differentially expressed throughout the rat colon.

M. Denis, N. Labarrière, G. Dabouis, 1994, The Biochemical journal.

A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer

M. Paesmans, J. Sculier, F. Ries, 1994 .

Phase I/II study of gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results.

D. Dunlop, D. Talbot, W. Steward, 1996, Seminars in oncology.

Feasibility and preliminary results of intensive chemotherapy and extensive irradiation in selected patients with limited small-cell lung carcinoma--results of three consecutive phase II programs.

J. Andrieu, G. Dabouis, Y. Coscas, 2000, Acta oncologica.

Evaluation of squamous cell carcinoma antigen as a new marker for lung cancer

M. Paesmans, J. Sculier, J. Body, 1990, Cancer.

A preliminary evaluation of calcitonin and PDN-21 as tumor markers for lung cancer. EORTC Lung Cancer Working Party.

J. Sculier, J. Body, J. Dumon, 1989, Henry Ford Hospital medical journal.

Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.

J. Sculier, J. Klastersky, J. Lecomte, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer. (NSCLC).

M. Paesmans, J. Sculier, J. Klastersky, 1996, Lung cancer.

Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer

M. Paesmans, J. Sculier, J. Klastersky, 1994 .

A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861.

J. Sculier, J. Klastersky, H. Lacroix, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized trial of two platinum combinations in patients with advanced non-small cell lung cancer: a preliminary report. European Organization for the Research and Treatment of Cancer--Lung Cancer Working Party.

J. Sculier, J. Klastersky, J. Lecomte, 1990, Seminars in oncology.

Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study.

D. Caillaud, D. Spaeth, A. Monnier, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic factors in diffuse malignant pleural mesothelioma. A study of 167 patients.

G. Dabouis, P. Germaud, A. D. de Lajartre, 1988, Chest.

A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer. EORTC Lung Cancer Working Party.

J. Sculier, J. Klastersky, J. Lecomte, 1990, Annals of oncology : official journal of the European Society for Medical Oncology.

Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party.

M. Paesmans, J. Sculier, F. Ries, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer

M. Paesmans, J. Sculier, J. Klastersky, 1990 .

Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells.

M. Grégoire, G. Dabouis, C. Ligeza-poisson, 2004, American journal of respiratory and critical care medicine.

[Efficacy of the combination of mitomycin, ifosfamide and cisplatin with irradiation for the treatment of cerebral metastasis in non small cell lung carcinoma].

J. Dutin, H. Lacroix, G. Dabouis, 1995, Bulletin du cancer.

Combination Chemotherapy with Ifosfamide and Nimustine (IMA) as Salvage Treatment for Small Cell Lung Cancer

M. Paesmans, J. Sculier, J. Klastersky, 1993 .

Efficacy of Navelbine (NVB) in non-small cell lung cancer (NSCLC).

E. Lemarié, J. Dalphin, A. Depierre, 1989, Seminars in oncology.

[Dilution hyponatremia and conserved natriuresis in pulmonary tuberculosis (author's transl)].

G. Dabouis, P. Peltier, R. Grossette, 1980, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.

Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice.

R. Stupp, J. Pujol, J. Douillard, 2000, Lung cancer.

[Improving organization of care could reduce referrals of cancer patients to the emergency department. Prospective analysis of 123 patients].

P. Le Conte, G. Dabouis, N. Denis, 2007, Presse medicale.

Experiences of parents and caregivers in pediatric intensive care units: A qualitative study.

B. Branger, J. Nizard, G. Durand, 2022, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[A rare and curable cause of acute respiratory insufficiency after a pneumonectomy. The platypnea-orthodeoxia syndrome by the reopening of the foramen ovale].

O. Darremont, G. Dabouis, P. Despins, 1992, Revue des maladies respiratoires.

[Desmoid tumors: diagnostic and therapeutic difficulties. Apropos of an unusual case].

D. Duveau, G. Dabouis, J. Michaud, 1992, Chirurgie; memoires de l'Academie de chirurgie.

Is the debate about single or double embryo transfer following in vitro fertilisation really an ethical dilemma?

P. Barrière, T. Fréour, P. Tessier, 2013 .

Systemic vasculitis in a patient with small-cell neuroendocrine bronchial cancer.

A. Moreau, D. Boutoille, T. Baranger, 1998, The European respiratory journal.

Correlation between multidrug resistance and the degree of differentiation of non-small-cell bronchopulmonary carcinoma (NSCLC) in vitro and in vivo.

C. Roussakis, C. Jacquot, C. Tomasoni, 1997, Anticancer research.

Abnormalities of the intracerebral vasculature in a case of neurofibromatosis.

L. Picard, J. Mussini, Y. Lajat, 1980, Journal of neuroradiology. Journal de neuroradiologie.

Combination Chemotherapy with Ifosfamide and Nimustine (IMA) as Salvage Treatment for Small Cell Lung Cancer

M. Paesmans, J. Sculier, J. Klastersky, 1993 .

Phase II trial of vindesine in malignant pleural mesothelioma.

C. Brambilla, B. Paramelle, J. Guerin, 1987, Cancer treatment reports.

Treatment of diffuse pleural malignant mesothelioma by cis dichloro diammine platinum (C.D.D.P.) in nine patients

G. Dabouis, J. Corroller, B. Mevel, 2004, Cancer Chemotherapy and Pharmacology.

[Epidemiology of malignant pleural mesothelioma in the Nantes-Saint Nazaire region. Course in 1956-1992].

G. Dabouis, P. Germaud, S. Chopra, 1995, Revue des maladies respiratoires.

193 Vinflunine (VFL) in first line treatment of malignant pleural mesothelioma (MPM): Final results of a European phase II study

D. Talbot, G. Dabouis, J. Margery, 2006 .

HpD-PDT for cancer treatment in bronchology.

T. Patrice, G. Dabouis, M. Foultier, 1987, Chest.

Neodymium-yttrium aluminium garnet laser destruction of nonsensitized and hematoporphyrin derivative-sensitized tumors.

L. Le Bodic, G Dabouis, T. Patrice, 1983, Cancer research.

Un diagnostic mené tambour battant

B. Dupas, A. Moreau, G. Dabouis, 1998 .

Combination chemotherapy with gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: preliminary results of an ongoing phase I/II study

D. Dunlop, D. Talbot, W. Steward, 1995, Anti-cancer drugs.